Loading…

The morning briefing, in your inbox.

Top Cyprus + world stories, summarised. Every day.

Developed by Muflon

GENESIS Pharma Expands Partnership with Alnylam Pharmaceuticals in Scandinavia · Cyprus Report

Economy · World

GENESIS Pharma Expands Partnership with Alnylam Pharmaceuticals in Scandinavia

2 sourcesFirst reported 1 month agoUpdated 1 month ago

AI summary: catch up in 20 seconds

GENESIS Pharma is expanding its commercial collaboration with Alnylam Pharmaceuticals.
The partnership now includes Denmark, Finland, Norway, and Sweden.
This expansion complements GENESIS Pharma's existing presence in thirteen Southeast European markets.
The focus of the collaboration is on RNAi therapies.

Generated by AI from the 2 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 2 sources below · always verify with the originals

Story timeline

18 June

Η GENESIS Pharma επεκτείνει τη συνεργασία με την Alnylam Pharmaceuticals για θεραπείες RNAi

Loading…

Η GENESIS Pharma επεκτείνει τη συνεργασία με την Alnylam Pharmaceuticals για θεραπείες RNAiCNN Greece · 1 month ago

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

GENESIS Pharma is expanding its commercial collaboration with Alnylam Pharmaceuticals.
The partnership now includes Denmark, Finland, Norway, and Sweden.
This expansion complements GENESIS Pharma's existing presence in thirteen Southeast European markets.
The focus of the collaboration is on RNAi therapies.

Generated by AI from the 2 sources below · always verify with the originals

18 June

Η GENESIS Pharma επεκτείνει τη συνεργασία με την Alnylam Pharmaceuticals για θεραπείες RNAi